Publications
191 found
Show per page
Andereggen, L., & Christ, E. (2024). Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study” [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 109(10), e1960–e1961. https://doi.org/10.1210/clinem/dgae383
Andereggen, L., & Christ, E. (2024). Letter to the Editor From Andereggen and Christ: “Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study” [Journal-article]. Journal of Clinical Endocrinology and Metabolism, 109(10), e1960–e1961. https://doi.org/10.1210/clinem/dgae383
Ebrahimi, Fahim, Andereggen, Lukas, & Reviews in Endocrine and Metabolic Disorders, 25(3), 599–608. https://doi.org/10.1007/s11154-024-09888-8
(2024). Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management.
Ebrahimi, Fahim, Andereggen, Lukas, & Reviews in Endocrine and Metabolic Disorders, 25(3), 599–608. https://doi.org/10.1007/s11154-024-09888-8
(2024). Morbidities and mortality among hospitalized patients with hypopituitarism: Prevalence, causes and management.
Hofland, Johannes, Refardt, Julie C., Feelders, Richard A., Journal of Clinical Endocrinology and Metabolism, 109(4), 1109–1118. https://doi.org/10.1210/clinem/dgad641
, & de Herder, Wouter W. (2024). Approach to the Patient: Insulinoma [Journal-article].
Hofland, Johannes, Refardt, Julie C., Feelders, Richard A., Journal of Clinical Endocrinology and Metabolism, 109(4), 1109–1118. https://doi.org/10.1210/clinem/dgad641
, & de Herder, Wouter W. (2024). Approach to the Patient: Insulinoma [Journal-article].
Beck, Julia, Siebenhüner, Alexander, Wild, Damian, Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/ERC-23-0235
, & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Beck, Julia, Siebenhüner, Alexander, Wild, Damian, Endocrine-Related Cancer, 31(3). https://doi.org/10.1530/ERC-23-0235
, & Refardt, Julie. (2024). Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms.
Ambrosini, Valentina, Caplin, Martyn, Castaño, Justo P., Journal of Neuroendocrinology, 36. https://doi.org/10.1111/jne.13359
, Denecke, Timm, Deroose, Christophe M., Dromain, Clarisse, Falconi, Massimo, Grozinsky-Glasberg, Simona, Hicks, Rodney J., Hofland, Johannes, Kjaer, Andreas, Knigge, Ulrich Peter, Kos-Kudla, Beata, Koumarianou, Anna, Krishna, Balkundi, Lamarca, Angela, Pavel, Marianne, Reed, Nicholas Simon, et al. (2024). Use and perceived utility of [ 18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
Ambrosini, Valentina, Caplin, Martyn, Castaño, Justo P., Journal of Neuroendocrinology, 36. https://doi.org/10.1111/jne.13359
, Denecke, Timm, Deroose, Christophe M., Dromain, Clarisse, Falconi, Massimo, Grozinsky-Glasberg, Simona, Hicks, Rodney J., Hofland, Johannes, Kjaer, Andreas, Knigge, Ulrich Peter, Kos-Kudla, Beata, Koumarianou, Anna, Krishna, Balkundi, Lamarca, Angela, Pavel, Marianne, Reed, Nicholas Simon, et al. (2024). Use and perceived utility of [ 18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
Andereggen, Lukas, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371468
. (2024). Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy.
Andereggen, Lukas, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371468
. (2024). Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy.
Andereggen, Lukas, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371424
. (2024). Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Andereggen, Lukas, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1371424
. (2024). Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.
Andereggen, Lukas, Gralla, Jan, & Acta Neurochirurgica, 166. https://doi.org/10.1007/s00701-024-06058-2
. (2024). The diagnostic yield of inferior petrosal sinus sampling in Cushing syndrome in the era of ovine CRH shortage.
Andereggen, Lukas, Gralla, Jan, & Acta Neurochirurgica, 166. https://doi.org/10.1007/s00701-024-06058-2
. (2024). The diagnostic yield of inferior petrosal sinus sampling in Cushing syndrome in the era of ovine CRH shortage.
Andereggen, Lukas, Tortora, Angelo, Schubert, Gerrit A., Musahl, Christian, Frey, Janine, Stieger, Andrea, Kobel, Béatrice, Luedi, Markus M., Roethlisberger, Michel, Mariani, Luigi, Beck, Jürgen, & Acta Neurochirurgica, 166. https://doi.org/10.1007/s00701-024-06213-9
. (2024). Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma.
Andereggen, Lukas, Tortora, Angelo, Schubert, Gerrit A., Musahl, Christian, Frey, Janine, Stieger, Andrea, Kobel, Béatrice, Luedi, Markus M., Roethlisberger, Michel, Mariani, Luigi, Beck, Jürgen, & Acta Neurochirurgica, 166. https://doi.org/10.1007/s00701-024-06213-9
. (2024). Characteristics and outcomes of men with erectile dysfunction as the presenting symptom due to a lactotroph adenoma.
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
, Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & Wild, Damian. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Fricke, Julia, Westerbergh, Frida, McDougall, Lisa, Favaretto, Chiara, European Journal of Nuclear Medicine and Molecular Imaging, 51, 2517–2519. https://doi.org/10.1007/s00259-024-06641-w
, Nicolas, Guillaume P., Geistlich, Susanne, Borgna, Francesca, Fani, Melpomeni, Bernhardt, Peter, van der Meulen, Nicholas P., Müller, Cristina, Schibli, Roger, & Wild, Damian. (2024). First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, Journal of Nuclear Medicine, 65, 228–235. https://doi.org/10.2967/jnumed.123.265894
, & Wild, Damian. (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis.
Friebe, Liene, Freitag, Martin T., Braun, Martin, Nicolas, Guillaume, Bauman, Andreas, Bushnell, David, Journal of Nuclear Medicine, 65, 228–235. https://doi.org/10.2967/jnumed.123.265894
, & Wild, Damian. (2024). Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis.
Huber, Markus, Luedi, Markus M., Schubert, Gerrit A., Musahl, Christian, Tortora, Angelo, Frey, Janine, Beck, Jürgen, Mariani, Luigi, Frontiers in Surgery, 11. https://doi.org/10.3389/fsurg.2024.1363431
, & Andereggen, Lukas. (2024). Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility.
Huber, Markus, Luedi, Markus M., Schubert, Gerrit A., Musahl, Christian, Tortora, Angelo, Frey, Janine, Beck, Jürgen, Mariani, Luigi, Frontiers in Surgery, 11. https://doi.org/10.3389/fsurg.2024.1363431
, & Andereggen, Lukas. (2024). Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utility.
Rottenburger, Christof, Hentschel, Michael, Fürstner, Markus, McDougall, Lisa, Kottoros, Danijela, Kaul, Felix, Mansi, Rosalba, Fani, Melpomeni, Vija, A. Hans, Schibli, Roger, Geistlich, Susanne, Behe, Martin, EJNMMI Research, 14. https://doi.org/10.1186/s13550-024-01101-w
, & Wild, Damian. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study.
Rottenburger, Christof, Hentschel, Michael, Fürstner, Markus, McDougall, Lisa, Kottoros, Danijela, Kaul, Felix, Mansi, Rosalba, Fani, Melpomeni, Vija, A. Hans, Schibli, Roger, Geistlich, Susanne, Behe, Martin, EJNMMI Research, 14. https://doi.org/10.1186/s13550-024-01101-w
, & Wild, Damian. (2024). In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study.
Schulte, Janine, Hotz, Gerhard, Szinnai, Gabor, BMC Medical Genomics, 17. https://doi.org/10.1186/s12920-024-01947-y
, Foderà, Gaspare, Krüsi, Karl, Nussberger, Peter, Kron, Sarah, & Schulz, Iris. (2024). Exploring the potential of genetic analysis in historical blood spots for patients with iodine-deficient goiter and thyroid carcinomas in Switzerland and Germany (1929–1989).
Schulte, Janine, Hotz, Gerhard, Szinnai, Gabor, BMC Medical Genomics, 17. https://doi.org/10.1186/s12920-024-01947-y
, Foderà, Gaspare, Krüsi, Karl, Nussberger, Peter, Kron, Sarah, & Schulz, Iris. (2024). Exploring the potential of genetic analysis in historical blood spots for patients with iodine-deficient goiter and thyroid carcinomas in Switzerland and Germany (1929–1989).
Borisov, Angel N., Kutz, Alexander, Journal of Clinical Endocrinology and Metabolism, 108(11), 2940–2949. https://doi.org/10.1210/clinem/dgad249
, Heim, Markus H., & Ebrahimi, Fahim. (2023). Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS.
Borisov, Angel N., Kutz, Alexander, Journal of Clinical Endocrinology and Metabolism, 108(11), 2940–2949. https://doi.org/10.1210/clinem/dgad249
, Heim, Markus H., & Ebrahimi, Fahim. (2023). Canagliflozin and Metabolic Associated Fatty Liver Disease in Patients With Diabetes Mellitus: New Insights From CANVAS.
Christ, E., Iacovazzo, D., Korbonits, M., & Perren, A. (2023). Insulinomatosis: new aspects. Endocrine-Related Cancer, 30(6). https://doi.org/10.1530/ERC-22-0327
Christ, E., Iacovazzo, D., Korbonits, M., & Perren, A. (2023). Insulinomatosis: new aspects. Endocrine-Related Cancer, 30(6). https://doi.org/10.1530/ERC-22-0327
Burman P., Trouillas J., Losa M., McCormack A., Petersenn S., Popovic V., Theodoropoulou M., Raverot G., Dekkers O.M., Guenego A., Micko A., Hubalewska-Dydejezky A., Troendle A., McCormack A., Rasmussen A.K., Whitelaw B., Decoudier B., Ekman B., Engstrom B.E., et al. (2022). Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. European Journal of Endocrinology, 187(4), 593–605. https://doi.org/10.1530/EJE-22-0440
Burman P., Trouillas J., Losa M., McCormack A., Petersenn S., Popovic V., Theodoropoulou M., Raverot G., Dekkers O.M., Guenego A., Micko A., Hubalewska-Dydejezky A., Troendle A., McCormack A., Rasmussen A.K., Whitelaw B., Decoudier B., Ekman B., Engstrom B.E., et al. (2022). Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. European Journal of Endocrinology, 187(4), 593–605. https://doi.org/10.1530/EJE-22-0440
Ebrahimi, Fahim, Kutz, Alexander, Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.940990
, & Szinnai, Gabor. (2022). Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study.
Ebrahimi, Fahim, Kutz, Alexander, Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.940990
, & Szinnai, Gabor. (2022). Lifetime risk and health-care burden of diabetic ketoacidosis: A population-based study.
Swiss Medical Weekly, 152(2930), w30197. https://doi.org/10.4414/SMW.2022.w30197
, Czock A, Renström F, Ammeter T, Ebrahimi F, Zechmann S, Kutz A, Diem P, Häuptle C, & Brändle M. (2022). Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.
Swiss Medical Weekly, 152(2930), w30197. https://doi.org/10.4414/SMW.2022.w30197
, Czock A, Renström F, Ammeter T, Ebrahimi F, Zechmann S, Kutz A, Diem P, Häuptle C, & Brändle M. (2022). Evaluation of type 2 diabetes care management in nine primary care practices before and after implementation of the Criteria of Good Disease Management of Diabetes established by the Swiss Society of Endocrinology and Diabetology.
Refardt J, Hofland J, Wild D., & Journal of Clinical Endocrinology and Metabolism, 107(7), E2662–E2670. https://doi.org/10.1210/clinem/dgac207
. (2022). Molecular Imaging of Neuroendocrine Neoplasms.
Refardt J, Hofland J, Wild D., & Journal of Clinical Endocrinology and Metabolism, 107(7), E2662–E2670. https://doi.org/10.1210/clinem/dgac207
. (2022). Molecular Imaging of Neuroendocrine Neoplasms.
Borbath I, Garcia-Carbonero R, Bikmukhametov D, Jimenez-Fonseca P, Castaño A, Barkmanova J, Sedlackova E, Kollár A, European Journal of Cancer, 168, 80–90. https://doi.org/10.1016/j.ejca.2022.03.007
, Kaltsas G, Kos-Kudla B, Maasberg S, Verslype C, & Pape UF. (2022). The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms.
Borbath I, Garcia-Carbonero R, Bikmukhametov D, Jimenez-Fonseca P, Castaño A, Barkmanova J, Sedlackova E, Kollár A, European Journal of Cancer, 168, 80–90. https://doi.org/10.1016/j.ejca.2022.03.007
, Kaltsas G, Kos-Kudla B, Maasberg S, Verslype C, & Pape UF. (2022). The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms.
Presse Medicale, 51(2), 104115. https://doi.org/10.1016/j.lpm.2022.104115
, Wild D, & Refardt J. (2022). Molecular Imaging in neuroendocrine neoplasias.
Presse Medicale, 51(2), 104115. https://doi.org/10.1016/j.lpm.2022.104115
, Wild D, & Refardt J. (2022). Molecular Imaging in neuroendocrine neoplasias.
Koehler V.F., Fuss CT, Berr C.M., Frank-Raue K., Raue F., Hoster E, Hepprich M., Clinical Endocrinology, 96(6), 847–856. https://doi.org/10.1111/cen.14617
, Pusl T., Reincke M, Spitzweg C., & Kroiss M. (2022). Medullary thyroid cancer with ectopic Cushing’s syndrome: A multicentre case series.
Koehler V.F., Fuss CT, Berr C.M., Frank-Raue K., Raue F., Hoster E, Hepprich M., Clinical Endocrinology, 96(6), 847–856. https://doi.org/10.1111/cen.14617
, Pusl T., Reincke M, Spitzweg C., & Kroiss M. (2022). Medullary thyroid cancer with ectopic Cushing’s syndrome: A multicentre case series.
Hofland J, Lamarca A, Steeds R, Toumpanakis C, Srirajaskanthan R, Riechelmann R, Panzuto F, Frilling A, Denecke T, Journal of Neuroendocrinology, 34(3), e13060. https://doi.org/10.1111/jne.13060
, Grozinsky-Glasberg S, Davar J, & ENETS Carcinoid Heart Disease Task Force. (2022). Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).
Hofland J, Lamarca A, Steeds R, Toumpanakis C, Srirajaskanthan R, Riechelmann R, Panzuto F, Frilling A, Denecke T, Journal of Neuroendocrinology, 34(3), e13060. https://doi.org/10.1111/jne.13060
, Grozinsky-Glasberg S, Davar J, & ENETS Carcinoid Heart Disease Task Force. (2022). Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force).
Huber M., Luedi MM, Schubert G.A., Musahl C, Tortora A, Frey J, Beck J., Mariani L., Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.810219
, & Andereggen L. (2022). Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas.
Huber M., Luedi MM, Schubert G.A., Musahl C, Tortora A, Frey J, Beck J., Mariani L., Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.810219
, & Andereggen L. (2022). Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas.
Fawcett C, Eppenberger-Castori S, Zechmann S, Hanke J, Herzog M, Savic Prince S, Acta Cytologica, 66(5), 371–378. https://doi.org/10.1159/000522662
, & Ebrahimi F. (2022). Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration.
Fawcett C, Eppenberger-Castori S, Zechmann S, Hanke J, Herzog M, Savic Prince S, Acta Cytologica, 66(5), 371–378. https://doi.org/10.1159/000522662
, & Ebrahimi F. (2022). Effects of Rapid On-Site Evaluation on Diagnostic Accuracy of Thyroid Fine-Needle Aspiration.
Andereggen L., Frey J., Andres R.H., Luedi M.M., El-Koussy M., Widmer H.R., Beck J, Mariani L., Seiler R.W., & Journal of Endocrinological Investigation, 44(12), 2621–2633. https://doi.org/10.1007/s40618-021-01569-6
. (2021). First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.
Andereggen L., Frey J., Andres R.H., Luedi M.M., El-Koussy M., Widmer H.R., Beck J, Mariani L., Seiler R.W., & Journal of Endocrinological Investigation, 44(12), 2621–2633. https://doi.org/10.1007/s40618-021-01569-6
. (2021). First-line surgery in prolactinomas: lessons from a long-term follow-up study in a tertiary referral center.
Andereggen L., Frey J, Andres R.H., Luedi M.M., Widmer H.R., Beck J, Mariani L., & Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-84606-x
. (2021). Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
Andereggen L., Frey J, Andres R.H., Luedi M.M., Widmer H.R., Beck J, Mariani L., & Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-84606-x
. (2021). Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas.
Ebrahimi F., Urwyler S.A., Betz M.J., Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-87207-w
, Schuetz P., Mueller B., Donath M.Y., & Christ-Crain M. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi F., Urwyler S.A., Betz M.J., Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-87207-w
, Schuetz P., Mueller B., Donath M.Y., & Christ-Crain M. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Refardt J, Hofland J, Wild D, & Current Oncology Reports, 23(12), 143. https://doi.org/10.1007/s11912-021-01139-2
. (2021). New Directions in Imaging Neuroendocrine Neoplasms.
Refardt J, Hofland J, Wild D, & Current Oncology Reports, 23(12), 143. https://doi.org/10.1007/s11912-021-01139-2
. (2021). New Directions in Imaging Neuroendocrine Neoplasms.
Theiler D., Cattaneo M, Dierickx L.O., Igaz P., Grozinsky-Glasberg S, Bournaud C., O’dorisio T., Sue O’Dorisio M., Wild D., Cancers, 13(24). https://doi.org/10.3390/cancers13246290
, & Nicolas GP. (2021). Safety and efficacy of peptide-receptor radionuclide therapy in elderly neuroendocrine tumor patients.
Theiler D., Cattaneo M, Dierickx L.O., Igaz P., Grozinsky-Glasberg S, Bournaud C., O’dorisio T., Sue O’Dorisio M., Wild D., Cancers, 13(24). https://doi.org/10.3390/cancers13246290
, & Nicolas GP. (2021). Safety and efficacy of peptide-receptor radionuclide therapy in elderly neuroendocrine tumor patients.
Walter M.A., Nesti C, Spanjol M, Kollár A, Bütikofer L, Gloy VL, Dumont RA, Seiler CA, Cochrane Database of Systematic Reviews, 2021(11). https://doi.org/10.1002/14651858.CD013700.pub2
, Radojewski P, Briel M, & Kaderli RM. (2021). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis.
Walter M.A., Nesti C, Spanjol M, Kollár A, Bütikofer L, Gloy VL, Dumont RA, Seiler CA, Cochrane Database of Systematic Reviews, 2021(11). https://doi.org/10.1002/14651858.CD013700.pub2
, Radojewski P, Briel M, & Kaderli RM. (2021). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis.
Andereggen L., Mariani L., Beck J, Andres R.H., Gralla J., Luedi M.M., Weis J., & Acta Neurochirurgica, 163(11), 3161–3169. https://doi.org/10.1007/s00701-021-04830-2
. (2021). Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort.
Andereggen L., Mariani L., Beck J, Andres R.H., Gralla J., Luedi M.M., Weis J., & Acta Neurochirurgica, 163(11), 3161–3169. https://doi.org/10.1007/s00701-021-04830-2
. (2021). Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort.
Berkmann S, Brun J., Schuetz P., Acta Neurochirurgica, 163(11), 3171–3180. https://doi.org/10.1007/s00701-021-04846-8
, Mariani L., & Mueller B. (2021). Prevalence and outcome of comorbidities associated with acromegaly.
Berkmann S, Brun J., Schuetz P., Acta Neurochirurgica, 163(11), 3171–3180. https://doi.org/10.1007/s00701-021-04846-8
, Mariani L., & Mueller B. (2021). Prevalence and outcome of comorbidities associated with acromegaly.
Gut L, Bernet S, Huembelin M, Mueller M, Baechli C, Koch D, Nebiker C, Schuetz P, Mueller B, European Thyroid Journal, 10(6), 476–485. https://doi.org/10.1159/000510618
, Ebrahimi F, & Kutz A. (2021). Sex-Specific Differences in Outcomes following Thyroidectomy: A Population-Based Cohort Study.
Gut L, Bernet S, Huembelin M, Mueller M, Baechli C, Koch D, Nebiker C, Schuetz P, Mueller B, European Thyroid Journal, 10(6), 476–485. https://doi.org/10.1159/000510618
, Ebrahimi F, & Kutz A. (2021). Sex-Specific Differences in Outcomes following Thyroidectomy: A Population-Based Cohort Study.
Mueller M., Ebrahimi F., Endocrine Connections, 10(10), 1273–1282. https://doi.org/10.1530/EC-21-0363
, Nebiker C.A., Schuetz P., Mueller B., & Kutz A. (2021). Safety of parathyroidectomy in older vs. younger patients with primary hyperparathyroidism.
Mueller M., Ebrahimi F., Endocrine Connections, 10(10), 1273–1282. https://doi.org/10.1530/EC-21-0363
, Nebiker C.A., Schuetz P., Mueller B., & Kutz A. (2021). Safety of parathyroidectomy in older vs. younger patients with primary hyperparathyroidism.
Refardt J, Hofland J, Kwadwo A, Nicolas GP, Rottenburger C, Fani M, Wild D, & Reviews in Endocrine and Metabolic Disorders, 22(3), 581–594. https://doi.org/10.1007/s11154-020-09552-x
. (2021). Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges.
Refardt J, Hofland J, Kwadwo A, Nicolas GP, Rottenburger C, Fani M, Wild D, & Reviews in Endocrine and Metabolic Disorders, 22(3), 581–594. https://doi.org/10.1007/s11154-020-09552-x
. (2021). Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges.
Andereggen L, Beck J, Gralla J, Luedi MM, & Letter to the Editor from Lukas Andereggen: “Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review” (Patent No. 8). 106(8), Article 8. https://doi.org/10.1210/clinem/dgab329
. (2021).
Andereggen L, Beck J, Gralla J, Luedi MM, & Letter to the Editor from Lukas Andereggen: “Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review” (Patent No. 8). 106(8), Article 8. https://doi.org/10.1210/clinem/dgab329
. (2021).
Wild D, Antwi K, Fani M, & Journal of Nuclear Medicine, 62(Suppl 2), 44S–50S. https://doi.org/10.2967/jnumed.120.246009
. (2021). Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
Wild D, Antwi K, Fani M, & Journal of Nuclear Medicine, 62(Suppl 2), 44S–50S. https://doi.org/10.2967/jnumed.120.246009
. (2021). Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
Antwi K, Wiesner P., Merkle E.M., Zech CJ, Boll DT, Wild D, PLoS ONE, 16(6 June 2021), e0253078. https://doi.org/10.1371/journal.pone.0253078
, & Heye T. (2021). Research article investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.
Antwi K, Wiesner P., Merkle E.M., Zech CJ, Boll DT, Wild D, PLoS ONE, 16(6 June 2021), e0253078. https://doi.org/10.1371/journal.pone.0253078
, & Heye T. (2021). Research article investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI.
Andereggen L, & Commentary: “Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery”. 12, 695498. https://doi.org/10.3389/fendo.2021.695498
. (2021).
Andereggen L, & Commentary: “Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery”. 12, 695498. https://doi.org/10.3389/fendo.2021.695498
. (2021).
Andereggen L, Frey J, & Endocrine, 72(1), 216–222. https://doi.org/10.1007/s12020-020-02557-1
. (2021). Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated.
Andereggen L, Frey J, & Endocrine, 72(1), 216–222. https://doi.org/10.1007/s12020-020-02557-1
. (2021). Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated.
Andereggen L., Frey J., Andres R.H., Luedi M.M., Gralla J., Schubert G.A., Beck J, Mariani L., & Journal of Clinical and Translational Endocrinology, 24. https://doi.org/10.1016/j.jcte.2021.100258
. (2021). Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term.
Andereggen L., Frey J., Andres R.H., Luedi M.M., Gralla J., Schubert G.A., Beck J, Mariani L., & Journal of Clinical and Translational Endocrinology, 24. https://doi.org/10.1016/j.jcte.2021.100258
. (2021). Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term.
Andereggen L, Gralla J, Schroth G, Mordasini P, Andres RH, Widmer HR, Luedi MM, Kellner F, Beck J, Mariani L, Ozdoba C, & Journal of Neuroradiology, 48(1), 10–15. https://doi.org/10.1016/j.neurad.2019.05.004
. (2021). Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing’s syndrome.
Andereggen L, Gralla J, Schroth G, Mordasini P, Andres RH, Widmer HR, Luedi MM, Kellner F, Beck J, Mariani L, Ozdoba C, & Journal of Neuroradiology, 48(1), 10–15. https://doi.org/10.1016/j.neurad.2019.05.004
. (2021). Influence of inferior petrosal sinus drainage symmetry on detection of adenomas in Cushing’s syndrome.
Hess, Gabriel Fridolin, Soysal, Savas Deniz, Nicolas, Guillaume, Bolli, Martin, Zech, Christoph Johannes, Tzankov, Alexandar, Case Reports in Surgery, 2021(8811155). https://doi.org/10.1155/2021/8811155
, Montemurro, Michael, & Kollmar, Otto. (2021). Surgical Strategy Based on Radiological 3D Reconstruction in a Giant Metastatic Neuroendocrine Tumor of the Pancreas: A Case Report of an Interdisciplinary Approach.
Hess, Gabriel Fridolin, Soysal, Savas Deniz, Nicolas, Guillaume, Bolli, Martin, Zech, Christoph Johannes, Tzankov, Alexandar, Case Reports in Surgery, 2021(8811155). https://doi.org/10.1155/2021/8811155
, Montemurro, Michael, & Kollmar, Otto. (2021). Surgical Strategy Based on Radiological 3D Reconstruction in a Giant Metastatic Neuroendocrine Tumor of the Pancreas: A Case Report of an Interdisciplinary Approach.
Martel-Duguech LM, Jorgensen JOL, Korbonits M, Johannsson G, Webb SM, Amadidou F, Mintziori G, Arosio M, Giavoli C, Badiu C, Boschetti M, Ferone D, Ricci Bitti S, Brue T, Albarel F, Cannavò S, Cotta OR, Carvalho D, Salazar D, et al. (2021). ESE audit on management of adult growth hormone deficiency in clinical practice. European Journal of Endocrinology, 184(2), 323–334. https://doi.org/10.1530/EJE-20-1180
Martel-Duguech LM, Jorgensen JOL, Korbonits M, Johannsson G, Webb SM, Amadidou F, Mintziori G, Arosio M, Giavoli C, Badiu C, Boschetti M, Ferone D, Ricci Bitti S, Brue T, Albarel F, Cannavò S, Cotta OR, Carvalho D, Salazar D, et al. (2021). ESE audit on management of adult growth hormone deficiency in clinical practice. European Journal of Endocrinology, 184(2), 323–334. https://doi.org/10.1530/EJE-20-1180
Ebrahimi F, Kutz A, Wagner U, Illigens B, Siepmann T, Schuetz P, Christ-Crain M, Mueller B, Mueller B, & Journal of Clinical Endocrinology and Metabolism, 105(11), 1–9. https://doi.org/10.1210/clinem/dgaa517
. (2020). Excess Mortality among Hospitalized Patients with Hypopituitarism—A Population-Based, Matched-Cohort Study.
Ebrahimi F, Kutz A, Wagner U, Illigens B, Siepmann T, Schuetz P, Christ-Crain M, Mueller B, Mueller B, & Journal of Clinical Endocrinology and Metabolism, 105(11), 1–9. https://doi.org/10.1210/clinem/dgaa517
. (2020). Excess Mortality among Hospitalized Patients with Hypopituitarism—A Population-Based, Matched-Cohort Study.
Refardt J, Zandee WT, Brabander T, Feelders RA, Franssen GJH, Hofland LJ, Endocrine-Related Cancer, 27(11), 615–624. https://doi.org/10.1530/ERC-20-0340
, de Herder WW, & Hofland J. (2020). Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging.
Refardt J, Zandee WT, Brabander T, Feelders RA, Franssen GJH, Hofland LJ, Endocrine-Related Cancer, 27(11), 615–624. https://doi.org/10.1530/ERC-20-0340
, de Herder WW, & Hofland J. (2020). Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging.
Antwi K, Hepprich M, Müller NA, Reubi JC, Fani M, Rottenburger C, Nicolas G, Kaul F, Clinical Nuclear Medicine, 45(9), E386–E392. https://doi.org/10.1097/RLU.0000000000003124
, & Wild D. (2020). Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging.
Antwi K, Hepprich M, Müller NA, Reubi JC, Fani M, Rottenburger C, Nicolas G, Kaul F, Clinical Nuclear Medicine, 45(9), E386–E392. https://doi.org/10.1097/RLU.0000000000003124
, & Wild D. (2020). Pitfalls in the Detection of Insulinomas With Glucagon-Like Peptide-1 Receptor Imaging.
Walter M.A., Spanjol M., Kollar A., Butikofer L., Gloy V.L., Dumont R.A., Seiler C.A., Cochrane Database of Systematic Reviews, 2020(8). https://doi.org/10.1002/14651858.CD013700
, Radojewski P., Briel M., & Kaderli R.M. (2020). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis.
Walter M.A., Spanjol M., Kollar A., Butikofer L., Gloy V.L., Dumont R.A., Seiler C.A., Cochrane Database of Systematic Reviews, 2020(8). https://doi.org/10.1002/14651858.CD013700
, Radojewski P., Briel M., & Kaderli R.M. (2020). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis.
Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollár A, Perren A, Annals of Surgical Oncology, 27(5), 1348–1355. https://doi.org/10.1245/s10434-019-08049-5
, Panzuto F, Pascher A, Jann H, Arsenic R, Cremer B, Kaemmerer D, Kump P, Lipp RW, Agaimy A, Wiedenmann B, Falconi M, & Pavel ME. (2020). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollár A, Perren A, Annals of Surgical Oncology, 27(5), 1348–1355. https://doi.org/10.1245/s10434-019-08049-5
, Panzuto F, Pascher A, Jann H, Arsenic R, Cremer B, Kaemmerer D, Kump P, Lipp RW, Agaimy A, Wiedenmann B, Falconi M, & Pavel ME. (2020). Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
Rottenburger C, Nicolas GP, McDougall L, Kaul F, Cachovan M, Vija AH, Schibli R, Geistlich S, Schumann A, Rau T, Glatz K, Behe M, Journal of Nuclear Medicine, 61(4), 520–523. https://doi.org/10.2967/jnumed.119.233031
, & Wild D. (2020). Cholecystokinin 2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma: Results of the lumed phase 0a study.
Rottenburger C, Nicolas GP, McDougall L, Kaul F, Cachovan M, Vija AH, Schibli R, Geistlich S, Schumann A, Rau T, Glatz K, Behe M, Journal of Nuclear Medicine, 61(4), 520–523. https://doi.org/10.2967/jnumed.119.233031
, & Wild D. (2020). Cholecystokinin 2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma: Results of the lumed phase 0a study.
Endocrine-Related Cancer, 27(4), R79–R92. https://doi.org/10.1530/ERC-19-0476
, Antwi K, Fani M, & Wild D. (2020). Innovative imaging of insulinoma: The end of sampling? a review.
Endocrine-Related Cancer, 27(4), R79–R92. https://doi.org/10.1530/ERC-19-0476
, Antwi K, Fani M, & Wild D. (2020). Innovative imaging of insulinoma: The end of sampling? a review.
Fuchs, Philipp S., Lötscher, Jonas, Berkemeier, Caroline M., Hirsiger, Julia R., Ghosh, Adhideb, Li, Quan-Zhen, Deigendesch, Nikolaus, Frontiers in Immunology, 11(11), 613130. https://doi.org/10.3389/fimmu.2020.613130
, Navarini, Alexander A., Recher, Mike, Daikeler, Thomas, Heijnen, Ingmar A. F. M., & Berger, Christoph T. (2020). Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients.
Fuchs, Philipp S., Lötscher, Jonas, Berkemeier, Caroline M., Hirsiger, Julia R., Ghosh, Adhideb, Li, Quan-Zhen, Deigendesch, Nikolaus, Frontiers in Immunology, 11(11), 613130. https://doi.org/10.3389/fimmu.2020.613130
, Navarini, Alexander A., Recher, Mike, Daikeler, Thomas, Heijnen, Ingmar A. F. M., & Berger, Christoph T. (2020). Co-Occurrence of ANCA-Associated Vasculitis and Sjögren’s Syndrome in a Patient With Acromegaly: A Case Report and Retrospective Single-Center Review of Acromegaly Patients.
Hepprich M, Antwi K, Waser B, Reubi JC, Wild D, Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging [Hindawi Limited410 Park Avenue, 15th Floor, 287 pmbNew YorkNY 10022]. 2020, 4510910. https://doi.org/10.1155/2020/4510910
, & . (2020).
Hepprich M, Antwi K, Waser B, Reubi JC, Wild D, Brunner’s Gland Hyperplasia in a Patient after Roux-Y Gastric Bypass: An Important Pitfall in GLP-1 Receptor Imaging [Hindawi Limited410 Park Avenue, 15th Floor, 287 pmbNew YorkNY 10022]. 2020, 4510910. https://doi.org/10.1155/2020/4510910
, & . (2020).
Reto M Kaderli, Marko Spanjol, Attila Kollár, , Lukas Bütikofer, Viktoria Gloy, Rebecca A Dumont, Christian A Seiler, Emanuel R Christ, JAMA Oncology.
, Matthias Briel, & Martin A Walter . (2020). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.
Reto M Kaderli, Marko Spanjol, Attila Kollár, , Lukas Bütikofer, Viktoria Gloy, Rebecca A Dumont, Christian A Seiler, Emanuel R Christ, JAMA Oncology.
, Matthias Briel, & Martin A Walter . (2020). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.
Dubach IL, Primary Care Diabetes, 13(6), 583–587. https://doi.org/10.1016/j.pcd.2019.05.007
, & Diem P. (2019). HbA1c-testing: Evaluation of two point-of-care analysers.
Dubach IL, Primary Care Diabetes, 13(6), 583–587. https://doi.org/10.1016/j.pcd.2019.05.007
, & Diem P. (2019). HbA1c-testing: Evaluation of two point-of-care analysers.
Antwi K, Nicolas G, Fani M, Heye T, Pattou F, Grossman A, Chanson P, Reubi JC, Perren A, Gloor B, Vogt DR, Wild D, & Journal of Clinical Endocrinology and Metabolism, 104(12), 5843–5852. https://doi.org/10.1210/jc.2018-02754
. (2019). Ga-Exendin-4 PET/CT Detects Insulinomas in Patients with Endogenous Hyperinsulinemic Hypoglycemia in MEN-1.
Antwi K, Nicolas G, Fani M, Heye T, Pattou F, Grossman A, Chanson P, Reubi JC, Perren A, Gloor B, Vogt DR, Wild D, & Journal of Clinical Endocrinology and Metabolism, 104(12), 5843–5852. https://doi.org/10.1210/jc.2018-02754
. (2019). Ga-Exendin-4 PET/CT Detects Insulinomas in Patients with Endogenous Hyperinsulinemic Hypoglycemia in MEN-1.
Antwi K, Nicolas G, Fani M, Clinical Nuclear Medicine, 44(5), E347–E348. https://doi.org/10.1097/RLU.0000000000002522
, & Wild D. (2019). Volume Replacement Fluid Demarks Benign Insulinoma with 68Ga-DOTA-Exendin-4 PET/CT.
Antwi K, Nicolas G, Fani M, Clinical Nuclear Medicine, 44(5), E347–E348. https://doi.org/10.1097/RLU.0000000000002522
, & Wild D. (2019). Volume Replacement Fluid Demarks Benign Insulinoma with 68Ga-DOTA-Exendin-4 PET/CT.
Kaderli RM, Spanjol M, Kollár A, Bütikofer L, Gloy V, Dumont RA, Seiler CA, JAMA Oncology, 5(4), 480–489. https://doi.org/10.1001/jamaoncol.2018.6720
, Radojewski P, Briel M, & Walter MA. (2019). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.
Kaderli RM, Spanjol M, Kollár A, Bütikofer L, Gloy V, Dumont RA, Seiler CA, JAMA Oncology, 5(4), 480–489. https://doi.org/10.1001/jamaoncol.2018.6720
, Radojewski P, Briel M, & Walter MA. (2019). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis.
Kwadwo A, Guillaume N, Wild D, & Swiss Medical Weekly, 149, w20076. https://doi.org/10.4414/smw.2019.20076
. (2019). Erratum to: Molecular imaging for neuroendeocrine tumours.
Kwadwo A, Guillaume N, Wild D, & Swiss Medical Weekly, 149, w20076. https://doi.org/10.4414/smw.2019.20076
. (2019). Erratum to: Molecular imaging for neuroendeocrine tumours.
Zulewski H, Giovanella L, Bilz S, Swiss Medical Weekly, 149, w14700. https://doi.org/10.4414/smw.2019.14700
, Haldemann A, Steinert H, Weidner S, Oertli D, Triponez F, Clerici T, Minder A, Dettmer M, & Komminoth P. (2019). Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland.
Zulewski H, Giovanella L, Bilz S, Swiss Medical Weekly, 149, w14700. https://doi.org/10.4414/smw.2019.14700
, Haldemann A, Steinert H, Weidner S, Oertli D, Triponez F, Clerici T, Minder A, Dettmer M, & Komminoth P. (2019). Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland.
Antwi K, Nicolas G, Wild D, & Swiss Medical Weekly, 149(9-10), w20017. https://doi.org/10.4414/smw.2019.20017
. (2019). Molecular imaging for neuroendocrine tumours.
Antwi K, Nicolas G, Wild D, & Swiss Medical Weekly, 149(9-10), w20017. https://doi.org/10.4414/smw.2019.20017
. (2019). Molecular imaging for neuroendocrine tumours.
Daly AF, Rostomyan L, Betea D, Bonneville JF, Villa C, Pellegata NS, Waser B, Reubi JC, Waeber Stephan C, Endocrine Connections, 8(4), 367–377. https://doi.org/10.1530/EC-19-0004
, & Beckers A. (2019). Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients.
Daly AF, Rostomyan L, Betea D, Bonneville JF, Villa C, Pellegata NS, Waser B, Reubi JC, Waeber Stephan C, Endocrine Connections, 8(4), 367–377. https://doi.org/10.1530/EC-19-0004
, & Beckers A. (2019). Aip-mutated acromegaly resistant to first-generation somatostatin analogs: Long-term control with pasireotide lar in two patients.
Meienberg, Fabian, Loher, Hannah, Bucher, Julie, Jenni, Stefan, Krüsi, Marion, Kreis, Roland, Boesch, Chris, Betz, Matthias Johannes, & Scientific Reports, 9(1), 19431. https://doi.org/10.1038/s41598-019-55942-w
. (2019). The effect of exercise on intramyocellular acetylcarnitine (AcCtn) concentration in adult growth hormone deficiency (GHD).
Meienberg, Fabian, Loher, Hannah, Bucher, Julie, Jenni, Stefan, Krüsi, Marion, Kreis, Roland, Boesch, Chris, Betz, Matthias Johannes, & Scientific Reports, 9(1), 19431. https://doi.org/10.1038/s41598-019-55942-w
. (2019). The effect of exercise on intramyocellular acetylcarnitine (AcCtn) concentration in adult growth hormone deficiency (GHD).
Rieben C., & Schweizer Zeitschrift Fur Gynakologie, 24(2), 9–12.
(2019). Prolactin - What’s new?: Hyperprolactinemia - Etiology, diagnostics, therapy Prolaktin – Was gibt’s Neues?
Rieben C., & Schweizer Zeitschrift Fur Gynakologie, 24(2), 9–12.
(2019). Prolactin - What’s new?: Hyperprolactinemia - Etiology, diagnostics, therapy Prolaktin – Was gibt’s Neues?
Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2318–2327. https://doi.org/10.1007/s00259-018-4101-5
, & Wild D. (2018). Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, European Journal of Nuclear Medicine and Molecular Imaging, 45(13), 2318–2327. https://doi.org/10.1007/s00259-018-4101-5
, & Wild D. (2018). Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
Valente LG, Antwi K, Nicolas GP, Wild D, & Swiss Medical Weekly, 148, w14682. https://doi.org/10.4414/smw.2018.14682
. (2018). Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: a neurological chameleon (observational study).
Valente LG, Antwi K, Nicolas GP, Wild D, & Swiss Medical Weekly, 148, w14682. https://doi.org/10.4414/smw.2018.14682
. (2018). Clinical presentation of 54 patients with endogenous hyperinsulinaemic hypoglycaemia: a neurological chameleon (observational study).
Loher H, Jenni S, Bucher J, Krüsi M, Kreis R, Boesch C, & Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 42-43, 32–39. https://doi.org/10.1016/j.ghir.2018.08.001
. (2018). Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise.
Loher H, Jenni S, Bucher J, Krüsi M, Kreis R, Boesch C, & Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 42-43, 32–39. https://doi.org/10.1016/j.ghir.2018.08.001
. (2018). Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise.
Hornemann T, Alecu I, Hagenbuch N, Zhakupova A, Cremonesi A, Gautschi M, Jung HH, Meienberg F, Bilz S, Molecular Genetics and Metabolism, 125(1-2), 73–78. https://doi.org/10.1016/j.ymgme.2018.07.003
, Baumgartner MR, & Hochuli M. (2018). Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
Hornemann T, Alecu I, Hagenbuch N, Zhakupova A, Cremonesi A, Gautschi M, Jung HH, Meienberg F, Bilz S, Molecular Genetics and Metabolism, 125(1-2), 73–78. https://doi.org/10.1016/j.ymgme.2018.07.003
, Baumgartner MR, & Hochuli M. (2018). Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, The New England Journal of Medicine, 379(5), 428–439. https://doi.org/10.1056/nejmoa1803760
, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, et al. (2018). A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, The New England Journal of Medicine, 379(5), 428–439. https://doi.org/10.1056/nejmoa1803760
, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, et al. (2018). A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.
Nicolas GP, Schreiter N, Kaul F, Uiters J, Bouterfa H, Kaufmann J, Erlanger TE, Cathomas R, Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(6), 915–921. https://doi.org/10.2967/jnumed.117.199760
, Fani M, & Wild D. (2018). Sensitivity Comparison of (68)Ga-OPS202 and (68)Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study.
Nicolas GP, Schreiter N, Kaul F, Uiters J, Bouterfa H, Kaufmann J, Erlanger TE, Cathomas R, Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 59(6), 915–921. https://doi.org/10.2967/jnumed.117.199760
, Fani M, & Wild D. (2018). Sensitivity Comparison of (68)Ga-OPS202 and (68)Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study.
Andereggen L., Hess B., Andres R.H., El-Koussy M., Mariani L., Raabe A., Seiler R.W., & Swiss Medical Weekly, 148(5-6). https://doi.org/10.4414/smw.2017.14521
(2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas.
Andereggen L., Hess B., Andres R.H., El-Koussy M., Mariani L., Raabe A., Seiler R.W., & Swiss Medical Weekly, 148(5-6). https://doi.org/10.4414/smw.2017.14521
(2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas.
Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brändle M, Guo M, Dang MN, Gabrovska P, Niederle B, Proceedings of the National Academy of Sciences of the United States of America, 115(5), 1027–1032. https://doi.org/10.1073/pnas.1712262115
, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, et al. (2018). MAFA missense mutation causes familial insulinomatosis and diabetes mellitus.
Iacovazzo D, Flanagan SE, Walker E, Quezado R, de Sousa Barros FA, Caswell R, Johnson MB, Wakeling M, Brändle M, Guo M, Dang MN, Gabrovska P, Niederle B, Proceedings of the National Academy of Sciences of the United States of America, 115(5), 1027–1032. https://doi.org/10.1073/pnas.1712262115
, Jenni S, Sipos B, Nieser M, Frilling A, Dhatariya K, et al. (2018). MAFA missense mutation causes familial insulinomatosis and diabetes mellitus.
Andereggen L, Hess B, Andres R, El-Koussy M, Mariani L, Raabe A, Seiler RW, & Swiss medical weekly, 148, w14521. https://doi.org/10.4414/smw.2018.14521
. (2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas.
Andereggen L, Hess B, Andres R, El-Koussy M, Mariani L, Raabe A, Seiler RW, & Swiss medical weekly, 148, w14521. https://doi.org/10.4414/smw.2018.14521
. (2018). A ten-year follow-up study of treatment outcome of craniopharyngiomas.
Körner M, Waser B, Neuroendocrinology, 106(2), 116–127. https://doi.org/10.1159/000472563
, Beck J, & Reubi JC. (2018). A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas.
Körner M, Waser B, Neuroendocrinology, 106(2), 116–127. https://doi.org/10.1159/000472563
, Beck J, & Reubi JC. (2018). A Critical Evaluation of sst3 and sst5 Immunohistochemistry in Human Pituitary Adenomas.
Notter A, Jenni S, & Swiss medical weekly, 148, w14586. https://doi.org/10.4414/smw.2018.14586
. (2018). Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland.
Notter A, Jenni S, & Swiss medical weekly, 148, w14586. https://doi.org/10.4414/smw.2018.14586
. (2018). Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland.
Sadowski SM, Endocrine connections, 7(1), 8–15. https://doi.org/10.1530/ec-17-0271
, Bédat B, Kollár A, Karenovics W, Perren A, Triponez F, & SwissNET registry. (2018). Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors.
Sadowski SM, Endocrine connections, 7(1), 8–15. https://doi.org/10.1530/ec-17-0271
, Bédat B, Kollár A, Karenovics W, Perren A, Triponez F, & SwissNET registry. (2018). Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors.
Andereggen L, Mono ML, Kellner-Weldon F, & Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 40, 62–64. https://doi.org/10.1016/j.jocn.2017.01.028
. (2017). Cluster headache and macroprolactinoma: Case report of a rare, but potential important causality.
Andereggen L, Mono ML, Kellner-Weldon F, & Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 40, 62–64. https://doi.org/10.1016/j.jocn.2017.01.028
. (2017). Cluster headache and macroprolactinoma: Case report of a rare, but potential important causality.
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & Endocrine, 55(1), 223–230. https://doi.org/10.1007/s12020-016-1115-2
. (2017). 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & Endocrine, 55(1), 223–230. https://doi.org/10.1007/s12020-016-1115-2
. (2017). 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & World neurosurgery, 97, 595–602. https://doi.org/10.1016/j.wneu.2016.10.059
. (2017). Long-Term Follow-Up of Primary Medical Versus Surgical Treatment of Prolactinomas in Men: Effects on Hyperprolactinemia, Hypogonadism, and Bone Health.
Andereggen L, Frey J, Andres RH, El-Koussy M, Beck J, Seiler RW, & World neurosurgery, 97, 595–602. https://doi.org/10.1016/j.wneu.2016.10.059
. (2017). Long-Term Follow-Up of Primary Medical Versus Surgical Treatment of Prolactinomas in Men: Effects on Hyperprolactinemia, Hypogonadism, and Bone Health.
Antwi, A., Fani, M., Heye, T., Nicolas, G., Merkle, E., Reubi, J. C., Gloor, B., Sensitivity of Glucagon-Like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI for the Localization of Benign Insulinomas: Interim Analysis of a Prospective Imaging Efficacy Study. 105, 163. KARGER.
, & Wild, D. (2017).
Antwi, A., Fani, M., Heye, T., Nicolas, G., Merkle, E., Reubi, J. C., Gloor, B., Sensitivity of Glucagon-Like Peptide-1 Receptor (GLP1-R) SPECT/CT, PET/CT and MRI for the Localization of Benign Insulinomas: Interim Analysis of a Prospective Imaging Efficacy Study. 105, 163. KARGER.
, & Wild, D. (2017).
Loher H, Kreis R, Boesch C, & International journal of molecular sciences, 17(9). https://doi.org/10.3390/ijms17091554
. (2016). The Flexibility of Ectopic Lipids.
Loher H, Kreis R, Boesch C, & International journal of molecular sciences, 17(9). https://doi.org/10.3390/ijms17091554
. (2016). The Flexibility of Ectopic Lipids.
Zueger T, Loher H, Egger A, Boesch C, & Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 29, 39–44. https://doi.org/10.1016/j.ghir.2016.03.007
. (2016). Regulation of fuel metabolism during exercise in hypopituitarism with growth hormone-deficiency (GHD).
Zueger T, Loher H, Egger A, Boesch C, & Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 29, 39–44. https://doi.org/10.1016/j.ghir.2016.03.007
. (2016). Regulation of fuel metabolism during exercise in hypopituitarism with growth hormone-deficiency (GHD).
Cuthbertson DJ, Banks M, Khoo B, Antwi K, Application of Ga(68) -DOTA-exendin-4 PET/CT to localize an occult insulinoma. (Patent No. 5). 84(5), Article 5. https://doi.org/10.1111/cen.12973
, Campbell F, Raraty M, & Wild D. (2016).
Cuthbertson DJ, Banks M, Khoo B, Antwi K, Application of Ga(68) -DOTA-exendin-4 PET/CT to localize an occult insulinoma. (Patent No. 5). 84(5), Article 5. https://doi.org/10.1111/cen.12973
, Campbell F, Raraty M, & Wild D. (2016).
Trombetti A, Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
, Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & Meier C. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms.
Trombetti A, Journal of Endocrinological Investigation, 39(5), 567–576. https://doi.org/10.1007/s40618-015-0423-3
, Henzen C, Gold G., Brändle M, Herrmann FR, Torriani C, Triponez F, Kraenzlin M, Rizzoli R, & Meier C. (2016). Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: A focus on neuro-behavioral and cognitive symptoms.
Scientific reports, 6, 19310. https://doi.org/10.1038/srep19310
, Egger A, Allemann S, Buehler T, Kreis R, & Boesch C. (2016). Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy.
Scientific reports, 6, 19310. https://doi.org/10.1038/srep19310
, Egger A, Allemann S, Buehler T, Kreis R, & Boesch C. (2016). Effects of aerobic exercise on ectopic lipids in patients with growth hormone deficiency before and after growth hormone replacement therapy.
Best practice & research. Clinical endocrinology & metabolism, 30(1), 1. https://doi.org/10.1016/j.beem.2016.02.011
. (2016). Preface - Neuroendocrine tumours.
Best practice & research. Clinical endocrinology & metabolism, 30(1), 1. https://doi.org/10.1016/j.beem.2016.02.011
. (2016). Preface - Neuroendocrine tumours.
Jenni S, Adler M, Lanz S, Taleghani BM, & Changes of Thyroid Hormones and Their Binding Proteins during Plasma Exchange for Polyneuropathy in a Patient with Substituted Hypothyroidism due to Hashimoto’s Thyroiditis. (No. 1; Vol. 43, pp. 45–49). https://doi.org/10.1159/000440822
. (2016).
Jenni S, Adler M, Lanz S, Taleghani BM, & Changes of Thyroid Hormones and Their Binding Proteins during Plasma Exchange for Polyneuropathy in a Patient with Substituted Hypothyroidism due to Hashimoto’s Thyroiditis. (No. 1; Vol. 43, pp. 45–49). https://doi.org/10.1159/000440822
. (2016).
Kaderli RM, Fahrner R, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 124(1), 45–48. https://doi.org/10.1055/s-0035-1565094
, Stettler C, Fuhrer J, Martinelli M, Vogt A, & Seiler CA. (2016). Total Thyroidectomy for Amiodarone-induced Thyrotoxicosis in the Hyperthyroid State.
Kaderli RM, Fahrner R, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 124(1), 45–48. https://doi.org/10.1055/s-0035-1565094
, Stettler C, Fuhrer J, Martinelli M, Vogt A, & Seiler CA. (2016). Total Thyroidectomy for Amiodarone-induced Thyrotoxicosis in the Hyperthyroid State.
Kollár A, Blank A, Perren A, Bütikofer L, Stettler C, & Swiss Medical Weekly, 146, w14362. https://doi.org/10.4414/smw.2016.14362
. (2016). Additional malignancies in patients with neuroendocrine tumours: analysis of the SwissNET registry.
Kollár A, Blank A, Perren A, Bütikofer L, Stettler C, & Swiss Medical Weekly, 146, w14362. https://doi.org/10.4414/smw.2016.14362
. (2016). Additional malignancies in patients with neuroendocrine tumours: analysis of the SwissNET registry.
Nicolas, G., Schreiter, N., Kaul, F., Uiters, J., Mena, R., Bauman, A., Bouterfa, H., Reubi, J. C., Rivier, J., Maecke, H., Cathomas, R., Somatostatin Receptor PET/CT with Radiolabelled Antagonist Is Twice as Effective as the Agonist for Detecting Liver Metastases: Results of a Phase 1/2 Study Comparing 68Ga-OPS202 with 68Ga-DOTATOC PET/CT in Gastroenteropancreatic NET Patients. 103, 60. KARGER.
, Fani, M., & Wild, D. (2016).
Nicolas, G., Schreiter, N., Kaul, F., Uiters, J., Mena, R., Bauman, A., Bouterfa, H., Reubi, J. C., Rivier, J., Maecke, H., Cathomas, R., Somatostatin Receptor PET/CT with Radiolabelled Antagonist Is Twice as Effective as the Agonist for Detecting Liver Metastases: Results of a Phase 1/2 Study Comparing 68Ga-OPS202 with 68Ga-DOTATOC PET/CT in Gastroenteropancreatic NET Patients. 103, 60. KARGER.
, Fani, M., & Wild, D. (2016).
Endocrine, 50(3), 821–823. https://doi.org/10.1007/s12020-015-0633-7
, Wild D, Antwi K, Waser B, Fani M, Schwanda S, Heye T, Schmid C, Baer HU, Perren A, & Reubi JC. (2015). Preoperative localization of adult nesidioblastosis using ⁶⁸Ga-DOTA-exendin-4-PET/CT.
Endocrine, 50(3), 821–823. https://doi.org/10.1007/s12020-015-0633-7
, Wild D, Antwi K, Waser B, Fani M, Schwanda S, Heye T, Schmid C, Baer HU, Perren A, & Reubi JC. (2015). Preoperative localization of adult nesidioblastosis using ⁶⁸Ga-DOTA-exendin-4-PET/CT.
Galimov A, Hartung A, Trepp R, Mader A, Flück M, Linke A, Blüher M, Journal of Molecular Medicine (Berlin, Germany), 93(12), 1369–1379. https://doi.org/10.1007/s00109-015-1322-y
, & Krützfeldt J. (2015). Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.
Galimov A, Hartung A, Trepp R, Mader A, Flück M, Linke A, Blüher M, Journal of Molecular Medicine (Berlin, Germany), 93(12), 1369–1379. https://doi.org/10.1007/s00109-015-1322-y
, & Krützfeldt J. (2015). Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance.
Locher R, Egger A, Zwimpfer C, Sze L, Schmid C, & Effect of Growth hormone replacement therapy on soluble Klotho in patients with Growth hormone deficiency. (Patent No. 4). 83(4), Article 4. https://doi.org/10.1111/cen.12756
. (2015).
Locher R, Egger A, Zwimpfer C, Sze L, Schmid C, & Effect of Growth hormone replacement therapy on soluble Klotho in patients with Growth hormone deficiency. (Patent No. 4). 83(4), Article 4. https://doi.org/10.1111/cen.12756
. (2015).
Antwi K, Fani M, Nicolas G, Rottenburger C, Heye T, Reubi JC, Gloor B, Journal of Nuclear Medicine, 56(7), 1075–1078. https://doi.org/10.2967/jnumed.115.157768
, & Wild D. (2015). Localization of hidden insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A pilot study.
Antwi K, Fani M, Nicolas G, Rottenburger C, Heye T, Reubi JC, Gloor B, Journal of Nuclear Medicine, 56(7), 1075–1078. https://doi.org/10.2967/jnumed.115.157768
, & Wild D. (2015). Localization of hidden insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A pilot study.
Hochuli M., Journal of Inherited Metabolic Disease, 38(6), 1093–1098. https://doi.org/10.1007/s10545-015-9864-2
, Meienberg F, Lehmann R., Krutzfeldt J., & Baumgartner M.R. (2015). Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.
Hochuli M., Journal of Inherited Metabolic Disease, 38(6), 1093–1098. https://doi.org/10.1007/s10545-015-9864-2
, Meienberg F, Lehmann R., Krutzfeldt J., & Baumgartner M.R. (2015). Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.
Wenning AS, Kirchner P, Antwi K, Fani M, Wild D, Patient Safety in Surgery, 9, 23. https://doi.org/10.1186/s13037-015-0064-7
, & Gloor B. (2015). Preoperative Glucagon-like peptide-1 receptor imaging reduces surgical trauma and pancreatic tissue loss in insulinoma patients: a report of three cases.
Wenning AS, Kirchner P, Antwi K, Fani M, Wild D, Patient Safety in Surgery, 9, 23. https://doi.org/10.1186/s13037-015-0064-7
, & Gloor B. (2015). Preoperative Glucagon-like peptide-1 receptor imaging reduces surgical trauma and pancreatic tissue loss in insulinoma patients: a report of three cases.
Zueger T, Bucher J, Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme, 39(7), 852–855. https://doi.org/10.1139/apnm-2013-0483
, & Stettler C. (2014). Peak oxygen uptake test in the assessment of growth hormone deficiency.
Zueger T, Bucher J, Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition et Metabolisme, 39(7), 852–855. https://doi.org/10.1139/apnm-2013-0483
, & Stettler C. (2014). Peak oxygen uptake test in the assessment of growth hormone deficiency.
Komor J, Reubi JC, & Pituitary, 17(3), 227–231. https://doi.org/10.1007/s11102-013-0494-0
. (2014). Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma.
Komor J, Reubi JC, & Pituitary, 17(3), 227–231. https://doi.org/10.1007/s11102-013-0494-0
. (2014). Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma.